The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists, and Institute for Safe Medication Practices today released recommendations emerging from a recent drug shortages summit, including recommendations for regulatory, legislative and other actions to address the ongoing shortages of critical medications affecting patient care. Among other actions, the recommendations include urging the Food and Drug Administration to share more information to help health care providers and manufacturers prepare for shortages. Other high-priority recommendations include conducting a Government Accountability Office study to identify new and emerging factors that contribute to shortages; developing a list of critical drugs essential for emergency response and preserving life; and offering incentives to manufacturers that create contingency production plans for pharmaceuticals on the critical drug list. The 19 recommendations were developed by participants at a recent summit examining vulnerabilities in the supply chain, U.S. dependence on foreign-sourced pharmaceutical ingredients, disaster planning and response efforts, and risk factors associated with pharmaceutical manufacturing and distribution.

Related News Articles

Headline
The Department of Health and Human Services has launched a webpage to help health care providers and families locate infant formula during the current national…
Headline
President Biden yesterday invoked the Defense Production Act to ensure manufacturers have the necessary ingredients to make infant formula in the United States…
Headline
The House Energy and Commerce Health Subcommittee today passed, as amended, the Restoring Hope for Mental Health and Well-being Act (H.R. 7666),…
Headline
In a letter today, AHA asked GE Healthcare to provide additional information to help member hospitals manage the current shortage of GE intraveneous…
Headline
The House Energy and Commerce Health Subcommittee yesterday voted unanimously to advance to the full committee the Restoring Hope for Mental Health and Well-…
Headline
The Food and Drug Administration is reporting shortages of GE Healthcare’s iohexol and iodixanol intraveneous contrast media products for computed…